Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

New Patent Office ruling on extensions hits drugmakers

Article Abstract:

The US Patent Office has ruled that drugmakers can use one of two patent extensions, but can not use both consecutively. The office had ruled earlier that extensions of 3 years allowed by the General Agreement on Tariffs and Trade and 5-year extensions for reviewing delays that were allowed under the Waxman-Hatch Act could be combined to protect patents for 25 years. The reversal reduces that to 23 years. Drug companies, such as Merck & Co, which could lose 19 months of protection for its Mecavor, may fight the rule in court.

Author: Borzo, Greg
Publisher: American Medical Association
Publication Name: American Medical News
Subject: Health
ISSN: 0001-1843
Year: 1995
Intellectual property, United States. Patent and Trademark Office, Patent extensions

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Pharmacists should not tell patients to switch drugs

Article Abstract:

The American Medical Assn criticized the drug firm practice of paying pharmacists who encourage pharmaceutical changes to their patients. Drug companies offer incentives to physicians but there are no plans for criticism and standards regarding their behavior. Pharmacists are paid consulting fees for these changes and certain physicians believe that this practice undermines the patient-physician relationship.

Author: Borzo, Greg
Publisher: American Medical Association
Publication Name: American Medical News
Subject: Health
ISSN: 0001-1843
Year: 1995
Pharmacies and Drug Stores, Pharmacists, Economic policy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


No more price restrictions on drugs created with NIH help

Article Abstract:

The National Institutes of Health (NIH) has scrapped its reasonable pricing clause, which required companies developing drugs and other products in cooperation with government researchers to give those products reasonable prices. NIH director Harold Varmus said that the clause has kept private industry from collaborating with Public Health Service researchers.

Author: Borzo, Greg
Publisher: American Medical Association
Publication Name: American Medical News
Subject: Health
ISSN: 0001-1843
Year: 1995
Scientific Research and Development Services, Medical Instruments and Supplies, Medical Instruments & Equipment, Medical Equipment and Supplies Manufacturing, National R&D Programs, Product development, Research, Medical equipment, United States. National Institutes of Health, Medical equipment and supplies industry, Medical equipment industry, Technology transfer

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Drugs, Laws, regulations and rules, Pharmaceutical industry
Similar abstracts:
  • Abstracts: Medical students protest perks from drug companies. Activists protest national parks proposal to profit from microbes
  • Abstracts: Online continuing dental education. Can technology help dentists deliver better patient care?
  • Abstracts: The effect of link nurses on hospital readmission rates. 'Cannabis can compound mental health problems'
  • Abstracts: Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers
  • Abstracts: 1-800-get-advice: phone counseling services are booming, as physicians and health plans seek new ways to managed patient use of medical care
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.